Methods and formulations of using a1 adenosine and p2x...

Details Methods and formulations of using a1 adenosine and p2x... Methods and formulations of using a1 adenosine and p2x...

A - Human Necessities

61

K

A61K 39/395 (2006.01) A61K 31/52 (2006.01) A61K 45/06 (2006.01) C07K 16/28 (2006.01)

Patent

CA 2444487

A1 adenosine receptor antagonists and P2X receptor antagonists are useful in the treatments of disorders of the immune system, which include HIV infection, AIDS, and adenosine deaminase deficiency-dependent severe immunodeficiency disease (ADA SCID).

Cette invention porte sur des antagonistes du récepteur de l'adénosine A¿1? et sur des antagonistes du récepteur P¿2x? qui servent au traitement de troubles du système immunitaire, tels que l'infection par VIH, le SIDA, et la maladie d'immunodéficience grave induite par un déficit en adénosine désaminase (ADA SCID).

Affiliated with

Also associated with

Rating

Methods and formulations of using a1 adenosine and p2x... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods and formulations of using a1 adenosine and p2x..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and formulations of using a1 adenosine and p2x... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1753132